Statistics in preclinical pharmaceutical research and development

被引：0

作者：

Gunter, B ^{[1
]}

Holder, D

机构：

[1] Merck Res Labs, Princeton, NJ 08540 USA

[2] Merck Res Labs, West Point, PA 19486 USA

来源：

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION | 2000年 / 95卷 / 451期

关键词：

D O I：

10.2307/2669485

中图分类号：

O21 [概率论与数理统计]; C8 [统计学];

学科分类号：

020208 ; 070103 ; 0714 ;

摘要：

引用

页码：998 / 1001

页数：4

共 50 条

[31] Pharmaceutical research and development and the patent system
Love, J
INTERNATIONAL JOURNAL OF HEALTH SERVICES, 2005, 35 (02): : 257 - 263
[32] The determinants of pharmaceutical research and development expenditures
Grabowski, H
Vernon, J
CAPITALISM AND DEMOCRACY IN THE 21ST CENTURY, 2001, : 207 - 221
[33] DEVELOPMENT OF INDUSTRIAL PHARMACEUTICAL RESEARCH IS ESSENTIAL
VIGNERON, M
PRODUCTS ET PROBLEMS PHARMACEUTIQUES, 1966, 21 (09): : 385 - &
[34] Nonprofit Organizations and Pharmaceutical Research and Development
Moos, Walter H.
Mirsalis, Jon C.
DRUG DEVELOPMENT RESEARCH, 2009, 70 (07) : 461 - 471
[35] Evolving ecosystem of pharmaceutical research and development
Christoffersen, Ralph E.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[36] Globalization of pharmaceutical research and development: A perspective
Desikan, Sridhar
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[37] Infrastructure of pharmaceutical research and development in Japan
Ono, S
Kodama, Y
Nagao, T
ANNALS OF PHARMACOTHERAPY, 2001, 35 (09) : 1122 - 1129
[38] The role of marketing in pharmaceutical research and development
Calfee, JE
PHARMACOECONOMICS, 2002, 20 (Suppl 3) : 77 - 85
[39] Artificial intelligence in pharmaceutical research and development
Mitchell, John B. O.
FUTURE MEDICINAL CHEMISTRY, 2018, 10 (13) : 1529 - 1531
[40] Revolution in pharmaceutical research and development - Consequences of genome research
Beyer, D
Steiner, M
NACHRICHTEN AUS DER CHEMIE, 2001, 49 (12) : 1427 - 1430

← 1 2 3 4 5 →